| Mr Johnathan David Goodwin, MD | |
|
3401 Springhill Dr, Suite 400, North Little Rock, AR 72117 | |
| (501) 945-3343 | |
| (501) 945-0770 |
| Full Name | Mr Johnathan David Goodwin |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 15 Years |
| Location | 3401 Springhill Dr, North Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295963379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 2011036079 (Missouri) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | E9623 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Medical Center North Little Rock | North little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastro Clinics Of Arkansas Pllc | 5496983363 | 8 |
News Archive
Savient Pharmaceuticals, Inc. announced that data providing further clarity and context surrounding the risk for and management of infusion reactions that may occur with KRYSTEXXA (pegloticase) in the treatment of refractory chronic gout (RCG) patients will be presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in Chicago.
Meanwhile, the health law's individual mandate could fall prey to deficit reduction efforts. And, in the background, congressional appropriators face especially unique challenges this year in trying to get their work done.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Proteome Sciences a leading provider of protein biomarker discovery, validation, and assay development services, today announced the formation of a strategic alliance to provide pharmaceutical companies with an expanded biomarker solution to allow earlier assessments in the development of new medicines.
A new study published in the American Journal of Transplantation reveals that cigarette smoke exposure, in a cause-effect manner, results in graft rejection that would have been prevented by certain drug treatments.
LivaNova PLC, a market-leading medical technology company, today announced the launch and enrollment of the first patient in the Global Prospective, Multi-center, Observational Post-market Study to Assess Short-, Mid- and Long-term Effectiveness and Efficiency of Vagus Nerve Stimulation Therapy® as Adjunctive Therapy in Real-world Patients with Difficult to Treat Depression.
› Verified 4 days ago
| Entity Name | Gastro Clinics Of Arkansas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972944064 PECOS PAC ID: 5496983363 Enrollment ID: O20140123000109 |
News Archive
Savient Pharmaceuticals, Inc. announced that data providing further clarity and context surrounding the risk for and management of infusion reactions that may occur with KRYSTEXXA (pegloticase) in the treatment of refractory chronic gout (RCG) patients will be presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in Chicago.
Meanwhile, the health law's individual mandate could fall prey to deficit reduction efforts. And, in the background, congressional appropriators face especially unique challenges this year in trying to get their work done.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Proteome Sciences a leading provider of protein biomarker discovery, validation, and assay development services, today announced the formation of a strategic alliance to provide pharmaceutical companies with an expanded biomarker solution to allow earlier assessments in the development of new medicines.
A new study published in the American Journal of Transplantation reveals that cigarette smoke exposure, in a cause-effect manner, results in graft rejection that would have been prevented by certain drug treatments.
LivaNova PLC, a market-leading medical technology company, today announced the launch and enrollment of the first patient in the Global Prospective, Multi-center, Observational Post-market Study to Assess Short-, Mid- and Long-term Effectiveness and Efficiency of Vagus Nerve Stimulation Therapy® as Adjunctive Therapy in Real-world Patients with Difficult to Treat Depression.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Johnathan David Goodwin, MD 3401 Springhill Dr, Suite 400, North Little Rock, AR 72117 Ph: (501) 945-3343 | Mr Johnathan David Goodwin, MD 3401 Springhill Dr, Suite 400, North Little Rock, AR 72117 Ph: (501) 945-3343 |
News Archive
Savient Pharmaceuticals, Inc. announced that data providing further clarity and context surrounding the risk for and management of infusion reactions that may occur with KRYSTEXXA (pegloticase) in the treatment of refractory chronic gout (RCG) patients will be presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in Chicago.
Meanwhile, the health law's individual mandate could fall prey to deficit reduction efforts. And, in the background, congressional appropriators face especially unique challenges this year in trying to get their work done.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Proteome Sciences a leading provider of protein biomarker discovery, validation, and assay development services, today announced the formation of a strategic alliance to provide pharmaceutical companies with an expanded biomarker solution to allow earlier assessments in the development of new medicines.
A new study published in the American Journal of Transplantation reveals that cigarette smoke exposure, in a cause-effect manner, results in graft rejection that would have been prevented by certain drug treatments.
LivaNova PLC, a market-leading medical technology company, today announced the launch and enrollment of the first patient in the Global Prospective, Multi-center, Observational Post-market Study to Assess Short-, Mid- and Long-term Effectiveness and Efficiency of Vagus Nerve Stimulation Therapy® as Adjunctive Therapy in Real-world Patients with Difficult to Treat Depression.
› Verified 4 days ago
Zafirah Salman, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3201 Springhill Dr Ste 350, North Little Rock, AR 72117 Phone: 501-945-0392 Fax: 501-945-0394 | |
Dr. William Wesley Thorpe, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3333 Springhill Dr, North Little Rock, AR 72117 Phone: 501-283-6000 | |
Charles R Caldwell Jr., M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3343 Springhill Dr, Suite 1035, North Little Rock, AR 72117 Phone: 501-975-7676 | |
Dr. Peter Michael Marvin, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3333 Springhill Dr, Administration, North Little Rock, AR 72117 Phone: 501-202-6945 Fax: 501-202-3813 | |
Dr. Jeffrey H Neuhauser, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3343 Springhill, Ste 1035 Arkansas Cardiology, North Little Rock, AR 72117 Phone: 501-975-7676 Fax: 501-975-0653 | |
Dr. Thomas D Conley, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3343 Springhill, St 1035, North Little Rock, AR 72117 Phone: 501-975-7676 Fax: 501-975-0653 | |
Dr. Ira Baim Gershner, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 505 W Pershing Blvd, Suite C, North Little Rock, AR 72114 Phone: 501-758-1138 Fax: 501-751-5114 |